Meet Paul Gudonis, CEO of Myomo

Related Posts

20 Aug

Technology gives legally blind Peoria boy a chance to fly

National Aviation Day isn’t a widely celebrated occasion, but it will be unforgettable nonetheless for Ryan Rusk.
The 12-year-old sixth…

read more
05 Jun

Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the addition of…

read more
20 Dec

Walmart’s 2016 holiday videos on YouTube have earned over 75M views – Insight from Pixability

Walmart’s push on YouTube this holiday season is paying off, earning the brand more than 75 million video views…

read more
05 Oct

YouTube shows 65% growth for beauty and personal care vids, Pixability study reveals

In its 4th annual beauty study, video advertising technology company, Pixability, reveals its latest beauty space social insights and…

read more
08 Jun

Ultracell Insulation $850000 Fundraising. Jonathan Strimling Filed Jun 7 Form D

Ultracell Insulation, Llc, Limited Liability Company just submitted form D about $850,000 debt financing. This is a new filing….

read more
23 Apr

eSight smart glasses help legally blind teen to see, shoot hoops with the Harlem Globetrotters

Ethan LaCroix, a 13-year-old boy who is legally blind, not only got to shoot hoops with the players of…

read more
07 Dec

Myomo, Inc. Announces Full Exercise of Underwriter’s Over-Allotment Option in Follow-On Public Offering

Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter…

read more
21 Jul

The Wearables Giving Computer Vision to the Blind

Other wearables use light and magnification to assist people with limited vision. A device called eSight, which users wear…

read more
28 Nov

Corbus Pharmaceuticals Expands Intellectual Property Portfolio with Patent Issuance Covering the Use of Anabasum for the Treatment of Rare Fibrotic Diseases

Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced…

read more
08 Sep

GE Ventures adds to $40M round for Andover industrial software company

The venture investment arm of General Electric Co. continues to show an interest in Massachusetts companies, this time by…

read more